Concepedia
Statistics
Publications
46
Citations
3.3K
H-Index
28
Active since
1987
Affiliations
Baxter (United States)(Current)
University of Rochester
Arbor Research Collaborative for Health
University of Michigan
Princess Alexandra Hospital
James A. Sloand is an author at Baxter (United States) specializing in medicine, nephrology, and hemodialysis.
Publications per year
1987–2022
B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximab
R. John Looney, Jennifer H. Anolik, Debbie Campbell et al. · Arthritis & Rheumatism · 2004 · 777 citations
Life Sciences, Immunology, Pharmacotherapy +16
Randomized, Double-Blind Trial of Antibiotic Exit Site Cream for Prevention of Exit Site Infection in Peritoneal Dialysis Patients
Judith Bernardini, Filitsa Bender, Tracey Florio et al. · Journal of the American Society of Nephrology · 2005 · 248 citations
Medicine, Pharmacology, Pharmacotherapy +13
A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome
James A. Sloand, Mark Shelly, Andrew Feigin et al. · American Journal of Kidney Diseases · 2004 · 207 citations
Medicine, Nephrology, Iron Metabolism Disorders +11
Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop
Allison Tong, Braden Manns, Angela Yee‐Moon Wang et al. · Kidney International · 2018 · 205 citations · Full text
Medicine, Health Services Administration, Nephrology +14
Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis
Ravindra L. Mehta, Glynis Scott, James A. Sloand et al. · The American Journal of Medicine · 1990 · 190 citations
Medicine, Nephrology, Pathology +16
1–5 of 46